| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |